catechin has been researched along with cyanoginosin lr in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, ZX; Shu, WQ; Xu, C; Yang, L; Zhang, L | 1 |
| Deng, H; Pan, H; Shi, J; Xu, Y; Zhang, M | 1 |
| Deng, H; Shi, J; Zhang, L; Zhang, M | 1 |
3 other study(ies) available for catechin and cyanoginosin lr
| Article | Year |
|---|---|
[The antagonistic action of epigallocatechin-3-gallate on microcystin LR-induced oxidative damage on hepatocytes of mice and the expression of cytochrome P450 2E1].
Topics: Animals; Catechin; Cytochrome P-450 CYP2E1; Hepatocytes; Male; Marine Toxins; Mice; Mice, Inbred BALB C; Microcystins; Oxidative Stress | 2010 |
Epigallocatechin-3-gallate attenuates microcystin-LR induced oxidative stress and inflammation in human umbilical vein endothelial cells.
Topics: Anti-Inflammatory Agents; Antioxidants; Catechin; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Interleukin-6; Marine Toxins; Microcystins; NF-kappa B p50 Subunit; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2017 |
Epigallocatechin-3-gallate attenuates microcystin-LR-induced apoptosis in human umbilical vein endothelial cells through activation of the NRF2/HO-1 pathway.
Topics: Antioxidants; Apoptosis; Caspase 3; Catechin; Cytochromes c; Gene Expression Regulation; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; Marine Toxins; Membrane Potential, Mitochondrial; Microcystins; Mitochondria; NF-E2-Related Factor 2; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Signal Transduction | 2018 |